A NEW large randomised trial just published in Clinical Therapeutics comparing a US formulation of Maxigesic to equivalent doses of paracetamol and ibuprofen shows that combined product provides significantly superior pain relief than either paracetamol or ibuprofen on their own.
The work, published in Clinical Therapeutics, showed Maxigesic also "reduced opioid rescue medication use and shortened time to meaningful pain relief".
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Dec 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Dec 18
